FI960423A0 - 4-merkapto-bentsoyyliguanidiinijohdannaiset - Google Patents

4-merkapto-bentsoyyliguanidiinijohdannaiset

Info

Publication number
FI960423A0
FI960423A0 FI960423A FI960423A FI960423A0 FI 960423 A0 FI960423 A0 FI 960423A0 FI 960423 A FI960423 A FI 960423A FI 960423 A FI960423 A FI 960423A FI 960423 A0 FI960423 A0 FI 960423A0
Authority
FI
Finland
Prior art keywords
bentsoyyliguanidiinijohdannaiset
mercapto
Prior art date
Application number
FI960423A
Other languages
English (en)
Swedish (sv)
Other versions
FI960423A (fi
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus-Otto Minck
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of FI960423A0 publication Critical patent/FI960423A0/fi
Publication of FI960423A publication Critical patent/FI960423A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Testing Resistance To Weather, Investigating Materials By Mechanical Methods (AREA)
FI960423A 1995-01-31 1996-01-30 4-merkapto-bentsoyyliguanidiinijohdannaiset FI960423A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19502895A DE19502895A1 (de) 1995-01-31 1995-01-31 4-Mercapto-benzoylguanidin-Derivate

Publications (2)

Publication Number Publication Date
FI960423A0 true FI960423A0 (fi) 1996-01-30
FI960423A FI960423A (fi) 1996-08-01

Family

ID=7752677

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960423A FI960423A (fi) 1995-01-31 1996-01-30 4-merkapto-bentsoyyliguanidiinijohdannaiset

Country Status (27)

Country Link
US (1) US5696167A (fi)
EP (1) EP0725062B1 (fi)
JP (1) JP3770947B2 (fi)
CN (1) CN1058001C (fi)
AR (1) AR002954A1 (fi)
AT (1) ATE202088T1 (fi)
AU (1) AU706843B2 (fi)
BR (1) BR9600263A (fi)
CA (1) CA2168319C (fi)
CO (1) CO4700519A1 (fi)
CZ (1) CZ290184B6 (fi)
DE (2) DE19502895A1 (fi)
DK (1) DK0725062T3 (fi)
ES (1) ES2159652T3 (fi)
FI (1) FI960423A (fi)
GR (1) GR3036344T3 (fi)
HU (1) HUP9600213A3 (fi)
NO (1) NO305834B1 (fi)
PL (1) PL181311B1 (fi)
PT (1) PT725062E (fi)
RU (1) RU2162079C2 (fi)
SI (1) SI0725062T1 (fi)
SK (1) SK281199B6 (fi)
TR (1) TR199600067A2 (fi)
TW (1) TW432036B (fi)
UA (1) UA43345C2 (fi)
ZA (1) ZA96701B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
KR20010080597A (ko) * 1998-11-26 2001-08-22 플레믹 크리스티안 인슐린 비의존성 당뇨병 치료를 위한 벤조일구아니딘의 용도
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
DE19951418A1 (de) * 1999-10-26 2001-05-03 Merck Patent Gmbh Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
TWI402261B (zh) 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE158278T1 (de) * 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
DE59305042D1 (de) * 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
TW250479B (fi) * 1992-12-15 1995-07-01 Hoechst Ag
DE4318658A1 (de) * 1993-06-04 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
CZ290184B6 (cs) 2002-06-12
AU4220096A (en) 1996-08-08
CN1134413A (zh) 1996-10-30
DE19502895A1 (de) 1996-08-01
UA43345C2 (uk) 2001-12-17
RU2162079C2 (ru) 2001-01-20
BR9600263A (pt) 1997-12-23
CZ27796A3 (en) 1996-10-16
CN1058001C (zh) 2000-11-01
NO960392L (no) 1996-08-01
NO305834B1 (no) 1999-08-02
US5696167A (en) 1997-12-09
CO4700519A1 (es) 1998-12-29
HUP9600213A2 (en) 1997-01-28
ES2159652T3 (es) 2001-10-16
AR002954A1 (es) 1998-05-27
JP3770947B2 (ja) 2006-04-26
EP0725062A1 (de) 1996-08-07
GR3036344T3 (en) 2001-11-30
HUP9600213A3 (en) 1998-07-28
ATE202088T1 (de) 2001-06-15
DE59607055D1 (de) 2001-07-19
PT725062E (pt) 2001-11-30
JPH08245560A (ja) 1996-09-24
PL312544A1 (en) 1996-08-05
NO960392D0 (no) 1996-01-30
CA2168319A1 (en) 1996-08-01
FI960423A (fi) 1996-08-01
CA2168319C (en) 2007-03-06
ZA96701B (en) 1997-04-16
EP0725062B1 (de) 2001-06-13
SK281199B6 (sk) 2001-01-18
TR199600067A2 (tr) 1996-08-21
SK12896A3 (en) 1996-09-04
HU9600213D0 (en) 1996-03-28
PL181311B1 (pl) 2001-07-31
AU706843B2 (en) 1999-06-24
TW432036B (en) 2001-05-01
DK0725062T3 (da) 2001-09-24
SI0725062T1 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
BR9609171A (pt) Fenilpiridazinonas
ATA135896A (de) Skibob
BR9607795A (pt) Fucopeptídeos
DE69623189D1 (de) Chipkartenabtaster
BR9605387A (pt) 1-azinil-tetrazolinonas
BR9603509A (pt) Piperidinilmetiloxazolidinonas
ATE198470T1 (de) Alkenyl-benzoylguanidine
DK0725062T3 (da) 4-Mercapto-benzoylguanidin-derivater
ATE240972T1 (de) Cyclopeptolide
BR9605050A (pt) Filatório
ATA119896A (de) Scheibenmähwerk
BR9503866A (pt) Autolabor
UA26010C2 (uk) Шарhірhе зчлеhуваhhя
FI1948U1 (fi) Doerrhaollare
BR7501376U (pt) Massarreal
BR7500991U (pt) Caríndio
BR7500825U (pt) Chutegol
BR7500838U (pt) Vassourágua
FIU960292U0 (fi) Pyykkinarukoukusto
BR7500437U (pt) Girolight
BR7500192U (pt) Parasitofiltro
BR7501399U (pt) Ciclonavegador
BR9502885A (pt) Casarreal
BR7502025U (pt) Kantil
BR7501298U (pt) Torre-audio-visual